Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aurora Cannabis Inc T.ACB

Alternate Symbol(s):  T.ACB.WS.U | ACB

Aurora Cannabis Inc. is a Canada-based medical cannabis company. The Company's principal business lines are focused on the production, distribution, and sale of cannabis related products in Canada and internationally. The Company’s segments include Canadian Cannabis, European Cannabis and Plant Propagation. The Company's adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being and Greybeard, as well as CBD brands, Reliva and KG7. Its medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, Bidiol and CraftPlant. Its cannabis products are primarily cultivated and manufactured in the facilities in Edmonton, Alberta; Bradford Ontario; Pemberton, British Columbia, and Odense, Denmark. The Company is focused on offering its cannabis products to global medical cannabis market, recreational cannabis market and global hemp-derived cannabidiol (CBD) markets.


TSX:ACB - Post by User

Bullboard Posts
Post by TexRitteron Dec 28, 2017 8:06pm
315 Views
Post# 27241952

Howdy Pardners

Howdy PardnersTex here again. Hitch your horses and set with me awhile by the campfire. There's a bottle o' spirits in that saddlebag behind you, coffee in the pot for those who don't partake. Help yerselves.

Now then....like others, I fully believe that THE number one stock to make profit short term would be ours - ACB - with the pending takeover. Longterm, it - right now, regardless -  is right there at the top with Canopy, nipping at those boys' boot-heels. Some laughed at my disclosure and appearance as a stock detective in the vein of Tom Horn; that matters not.

Come mid January, the good folks at Cannimed will cast their vote on Newstrike. I would be surprised if we go much past 9 before that. Possible, but I think we may meet resistance now at 9, then prior to 9.50, unitl that vote happens.

But when that vote happens - and I reckon the majority of CMed folks, being for the most part sharper than your average steer will agree with me - I believe the vote will be turned down. This will point to a landslide vote FOR merging with us. Now when that happens - and I do mean first the Newstrike vote turning it down - - watch this stock shoot like a Spencer Rifle into the 12 dollar range within 2 weeks tops. Then watch it meet and pass, in order, MedReleaf and Aphria, shortly after the vote to merge. And come the early spring, it will be the second company to move  past 25 dollars pushing 30. 

So that's that....now rest for a spell; get some shuteye. I'll be moseying up the trail aways, check on the lay of the land for tomorrow. Shaping up to be a fine day.


Bullboard Posts